With our training nearing the end, my fundraising is still going strong and continues past the actual marathon. This past week though was a great week and we have now raised $11,969!! An amazing number and just over $1,100 short of the $13,100 goal. This brings our 5-year total to $61,372!! Looking back at this experience I'll remember the marathons for certain but I'll also remember the support from so many people that helped raise $61,372 for DFMC and innovative cancer research. I look forward to seeing what new treatments and hopefully cures come to from Dana-Farber researchers in the future. Thank you again for all your support!
Running in honor and support of Chris Davie and his family as Chris battles glioblastoma. Fundraising to support The Claudia Adams Barr Program for Innovative Cancer Research at Dana-Farber while training for my 7th Boston Marathon with DFMC. We have raised over $83,000 during my previous 6 years and aim to surpass $100,000 this year!
About Me
- chris
- My Goal: Run the Boston Marathon on April 15, 2019 with the Dana-Farber Marathon Challenge. Raise $17,000 (or more!) where 100% of funds raised benefit the Claudia Adams Barr Program in Innovative Basic Cancer Research. I run in honor of my friend Chris Davie who is battling brain cancer. I also run in honor for my friend RJ and his continued cancer-free life, in memory of Heather Thomson, and for other family and friends who are or have battled cancer. Together we can help Dana-Farber Cancer Institute reach the ultimate finish line: a world without cancer
Barr Program Impact Statements
Barr Program Impact Statements
Immunotherapies: New Ways to Activate the Immune System—An important area of cancer research asks why the human body's defense systems do not always attack and destroy tumors as they form. Funded by the Claudia Adams Barr Program, Glenn Dranoff, MD, discovered complex regulatory pathways in the human immune system that cancers exploit in order to escape destruction. Reversal of these effects can lead to the development of vaccines against cancer, like Provenge for prostate cancer. This research has also enabled the development of immune-activating drugs such as ipilimumab, which showed striking effects in melanoma in a trial led by Dana-Farber scientists and is now approved by the Food and Drug Administration for treatment.
Sunday, April 10, 2016
Final DFMC Training Run
With our training nearing the end, my fundraising is still going strong and continues past the actual marathon. This past week though was a great week and we have now raised $11,969!! An amazing number and just over $1,100 short of the $13,100 goal. This brings our 5-year total to $61,372!! Looking back at this experience I'll remember the marathons for certain but I'll also remember the support from so many people that helped raise $61,372 for DFMC and innovative cancer research. I look forward to seeing what new treatments and hopefully cures come to from Dana-Farber researchers in the future. Thank you again for all your support!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment